Rob Kirk

Rob Kirk has a diverse range of work experience in various industries, particularly in the field of corporate finance and advisory. Rob Kirk has held the role of Managing Partner Corporate Finance at BizAdvisoryBoard since 2020, where they provide advisory consulting services for corporate finance alternatives. Rob Kirk specializes in areas such as mergers and acquisitions, acquisition strategy, reverse mergers, securities law considerations, and capital needs.

In 2022, Rob Kirk also served as a Senior Capital Markets Advisor at Intiva Health, a growing manufacturer in the gummies industry. Rob Kirk provided expertise in capital markets and M&A advisory services. Additionally, they held the position of Senior Corporate Finance Advisor at CROWN METALS LLC in the same year, where they offered capital markets and M&A advisory services for a metal and recycling company executing a rollup strategy.

In terms of specific industry focus, Rob Kirk had a role as Chief Financial Officer at Integrity Cannabis Solutions, Inc. in 2021, overseeing laboratory biosynthesis for CBD and THC using bioreactor technology. Rob Kirk also served as a Member of the Board of Directors at Valvecure, LLC from 2023 onwards, contributing their expertise to innovative cardiac technology for the therapeutic treatment of Mitral Regurgitation.

Prior to these roles, Rob Kirk held positions at Saikou Optics Inc as a Senior Advisor from 2015 to 2016, and at Oz Merchant Bankers as a Private Equity Risk Analyst/Corporate Finance from 2017 to 2021. Rob Kirk has also worked as a Senior Advisor at Island Pharmaceuticals from 2017 to 2021. Before these roles, they worked independently as an Investment Banking/Corporate Finance Advisor, providing advisory services for projects such as project financing for Pacific Imperial Railway and establishing non-profits and funding for Valvecure LLC and heartforthecure.org.

Overall, Rob Kirk's work experience showcases their expertise in corporate finance, capital markets, mergers and acquisitions, and advisory consulting across a wide range of industries, particularly in the Asian and life science markets.

Rob Kirk, C-Level Financial Advisor to Asian and Life Science Markets, holds a Juris Doctor (J.D.) degree from California Southern University. Rob Kirk completed their legal education from 2005 to 2010. Prior to pursuing law, they attended The Ohio State University from 1979 to 1983, where they earned a Bachelor of Science (B.S.) degree in genetics. During the same period, Rob also obtained a degree in Physiological Optics, resulting in a Doctor of Optometry (O.D.) qualification. Additionally, they hold the certification of "Dr. of Optometry" from the State of California - Board of Optometry, although the specific month and year of obtaining this certification is not provided.